JP2010504307A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010504307A5 JP2010504307A5 JP2009528740A JP2009528740A JP2010504307A5 JP 2010504307 A5 JP2010504307 A5 JP 2010504307A5 JP 2009528740 A JP2009528740 A JP 2009528740A JP 2009528740 A JP2009528740 A JP 2009528740A JP 2010504307 A5 JP2010504307 A5 JP 2010504307A5
- Authority
- JP
- Japan
- Prior art keywords
- packing
- satraplatin
- day
- administration
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CKNPWBAXEKSCRG-UHFFFAOYSA-J satraplatin Chemical compound CC(=O)O[Pt-2]([NH3+])(Cl)(Cl)(OC(C)=O)[NH2+]C1CCCCC1 CKNPWBAXEKSCRG-UHFFFAOYSA-J 0.000 claims 29
- 229960005399 satraplatin Drugs 0.000 claims 29
- 239000003814 drug Substances 0.000 claims 26
- 239000003246 corticosteroid Substances 0.000 claims 14
- 238000002512 chemotherapy Methods 0.000 claims 12
- 206010062904 Hormone-refractory prostate cancer Diseases 0.000 claims 5
- 206010061289 Metastatic neoplasm Diseases 0.000 claims 5
- 230000003474 anti-emetic Effects 0.000 claims 5
- 239000002111 antiemetic agent Substances 0.000 claims 5
- 230000001394 metastastic Effects 0.000 claims 5
- 230000001472 cytotoxic Effects 0.000 claims 4
- 231100000433 cytotoxic Toxicity 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 claims 3
- 229960001334 Corticosteroids Drugs 0.000 claims 3
- MFWNKCLOYSRHCJ-BTTYYORXSA-N Granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 claims 3
- 229960003727 Granisetron Drugs 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 claims 3
- 206010061818 Disease progression Diseases 0.000 claims 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N Docetaxel Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
- 229960001842 Estramustine Drugs 0.000 claims 2
- FRPJXPJMRWBBIH-RBRWEJTLSA-N Estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 claims 2
- KKZJGLLVHKMTCM-UHFFFAOYSA-N Mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 2
- 229960001156 Mitoxantrone Drugs 0.000 claims 2
- 210000002784 Stomach Anatomy 0.000 claims 2
- 229960003048 Vinblastine Drugs 0.000 claims 2
- HOFQVRTUGATRFI-XQKSVPLYSA-N Vinblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 HOFQVRTUGATRFI-XQKSVPLYSA-N 0.000 claims 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 2
- 229940045698 antineoplastic Taxanes Drugs 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229960003668 docetaxel Drugs 0.000 claims 2
- 239000002895 emetic Substances 0.000 claims 2
- 230000000095 emetic Effects 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000004083 survival Effects 0.000 claims 2
- 208000009956 Adenocarcinoma Diseases 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229960001592 Paclitaxel Drugs 0.000 claims 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims 1
- 210000002307 Prostate Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000001794 hormone therapy Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229960004618 prednisone Drugs 0.000 claims 1
- 230000002035 prolonged Effects 0.000 claims 1
- 229930003347 taxol Natural products 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84696806P | 2006-09-24 | 2006-09-24 | |
| US90300807P | 2007-02-22 | 2007-02-22 | |
| US90318007P | 2007-02-23 | 2007-02-23 | |
| EP07114786A EP1905439A1 (en) | 2006-09-24 | 2007-08-22 | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| PCT/EP2007/060112 WO2008034909A2 (en) | 2006-09-24 | 2007-09-24 | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010504307A JP2010504307A (ja) | 2010-02-12 |
| JP2010504307A5 true JP2010504307A5 (US20070167479A1-20070719-C00034.png) | 2011-02-24 |
Family
ID=38670505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528740A Pending JP2010504307A (ja) | 2006-09-24 | 2007-09-24 | サトラプラチンを使用する転移性ホルモン不応性前立腺癌の二次治療 |
Country Status (6)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905437A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Treatment of pain using satraplatin |
| WO2010132594A1 (en) * | 2009-05-12 | 2010-11-18 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat prostate cancer |
| US8809562B2 (en) | 2011-06-06 | 2014-08-19 | Chevron Phillips Chemical Company Lp | Use of metallocene compounds for cancer treatment |
| CN104661658A (zh) | 2012-09-26 | 2015-05-27 | 阿拉贡药品公司 | 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素 |
| JOP20200097A1 (ar) * | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| CN111479560A (zh) | 2017-10-16 | 2020-07-31 | 阿拉贡药品公司 | 用于治疗非转移性去势难治性前列腺癌的抗雄激素 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005007471D1 (de) * | 2004-02-18 | 2008-07-24 | Gpc Biotech Ag | Satraplatin zur behandlung von resistenten oder refrkatären tumoren |
| US20060205810A1 (en) * | 2004-11-24 | 2006-09-14 | Schering Corporation | Platinum therapeutic combinations |
| ES2327421T3 (es) * | 2005-03-11 | 2009-10-29 | Gpc Biotech Ag | Terapia antiproliferativa combinada que comprende satraplatino o jm118 y docetaxel. |
| EP1792622A1 (en) * | 2005-11-11 | 2007-06-06 | GPC Biotech AG | Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues |
| EP1905437A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Treatment of pain using satraplatin |
-
2007
- 2007-08-22 EP EP07114786A patent/EP1905439A1/en not_active Withdrawn
- 2007-09-21 TW TW096135597A patent/TW200820981A/zh unknown
- 2007-09-24 EP EP07820518A patent/EP2066311A2/en not_active Withdrawn
- 2007-09-24 JP JP2009528740A patent/JP2010504307A/ja active Pending
- 2007-09-24 AR ARP070104209A patent/AR062960A1/es unknown
- 2007-09-24 WO PCT/EP2007/060112 patent/WO2008034909A2/en active Application Filing
- 2007-09-24 US US12/311,032 patent/US20090312295A1/en not_active Abandoned
